2SEVENTY BIO

2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment. The company combines a deep knowledge of cancer cell biology and genetics with an understanding of the immune response to cancer to advance its pipeline. It was established in Cambridge, Massachusetts in 2021.

#SimilarOrganizations #People #Financial #Event #Website #More

2SEVENTY BIO

Social Links:

Twitter

Instagram

Industry:

Biotechnology Genetics Health Care Therapeutics

Founded:

2021-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.2seventybio.com

Total Employee:

251+

Status:

Active

Contact:

617-675-7270

Email Addresses:

[email protected]

Total Funding:

170 M USD

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

cogent-biosciences-logo

Cogent Biosciences

Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

vor-biopharma-logo

Vor Biopharma

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Current Employees Featured

susan-abu-absi_image

Susan Abu-Absi
Susan Abu-Absi Chief Technology & Manufacturing Officer @ 2seventy bio
Chief Technology & Manufacturing Officer
2022-01-01

greg-fralish_image

Greg Fralish
Greg Fralish Vice President, Head of Corporate Development @ 2seventy bio
Vice President, Head of Corporate Development
2021-11-01

nick-leschly_image

Nick Leschly
Nick Leschly Chief Kairos Officer @ 2seventy bio
Chief Kairos Officer
2021-11-01

philip-gregory_image

Philip Gregory
Philip Gregory Chief Scientific Officer @ 2seventy bio
Chief Scientific Officer

steven-h-bernstein_image

Steven H. Bernstein
Steven H. Bernstein CMO @ 2seventy bio
CMO
2022-02-01

nicola-heffron_image

Nicola Heffron
Nicola Heffron Chief Operating Officer @ 2seventy bio
Chief Operating Officer

william-baird_image

William Baird
William Baird Chief Financial Officer @ 2seventy bio
Chief Financial Officer

aura-mackenzie_image

Aura Mackenzie
Aura Mackenzie Senior Director, Oncology Commercial and Program Strategy @ 2seventy bio
Senior Director, Oncology Commercial and Program Strategy
2021-11-01

Stock Details

Company's stock symbol is NASDAQ:TSVT

Investors List

madison-avenue-partners_image

Key Employee Changes

Date	New article
2022-02-14	2seventy bio plucks Turnstone Biologics exec Bernstein to be new CMO

Official Site Inspections

http://www.2seventybio.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.43 K

Host Informations
Whois Informations

Loading ...